
|Articles|November 13, 2015
Approvals of New Lung Cancer, Melanoma Drugs Highlight Specialty Pharmacy Week in Review
Author(s)Davy James, Managing Editor
Top stories of the week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/approvals-of-new-lung-cancer-melanoma-drugs-highli" target="_blank">View the story "Approvals of New Lung Cancer, Melanoma Drugs Highlight Specialty Pharmacy Week in Review" on Storify</a>]
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacists at the Forefront: Initiating, Monitoring, and Identifying Candidates for VMAT2 Therapy
2
FDA Accepts NDA for AD109 for Treatment of Adults With Obstructive Sleep Apnea
3
Workforce Preparation for Fall Immunization Season Starts Now
4
Investigational mRNA Flu Vaccine Broadens Antibody Defenses, Sustains Immune "Training Hub" Longer Than Standard Shot
5






































































































